IMPACT OF NEW DRUGS AND BIOLOGICALS ON TREATMENT AND COSTS FOR COLORECTAL CANCER

被引：0
|
作者：
Shah, N. D. [1 ]
Van Houten, H. [1 ]
Vermeulen, L. [2 ]
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Univ Wisconsin Hosp & Clin, Madison, WI 53792 USA
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)73343-X
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A56 / A56
页数：1
相关论文
共 50 条
  • [41] New drugs in therapy of colorectal cancer: Preclinical studies
    Rustum, YM
    Cao, SS
    SEMINARS IN ONCOLOGY, 1999, 26 (06) : 612 - 620
  • [42] Antiangiogehic Drugs for Colorectal Cancer: Exploring New Possibilities
    Ferrarotto, Renata
    Hoff, Paulo M.
    CLINICAL COLORECTAL CANCER, 2013, 12 (01) : 1 - 7
  • [43] Treatment pathways and associated costs of metastatic colorectal cancer in Greece
    Ioannis Sougklakos
    Elias Athanasiadis
    Ioannis Boukovinas
    Michalis Karamouzis
    Aggelos Koutras
    Paulos Papakotoulas
    Dimitra Latsou
    Magda Hatzikou
    Eugena Stamuli
    Athanasios Balasopoulos
    Aggelos Sideris
    Cost Effectiveness and Resource Allocation, 20
  • [44] Long-term costs of colorectal cancer treatment in Spain
    Corral, Julieta
    Castells, Xavier
    Molins, Eduard
    Chiarello, Pietro
    Maria Borras, Josep
    Cots, Francesc
    BMC HEALTH SERVICES RESEARCH, 2016, 16
  • [45] SURVEY AND ANALYSIS OF THE COSTS OF METASTATIC COLORECTAL CANCER TREATMENT IN SERBIA
    Rutkowski, J.
    Haldas, M.
    Jedynasty, K.
    VALUE IN HEALTH, 2010, 13 (07) : A262 - A263
  • [46] Screening, prevention and socioeconomic costs associated with the treatment of colorectal cancer
    Alberto Redaelli
    Carole W. Cranor
    Gary J. Okano
    Pat Ray Reese
    PharmacoEconomics, 2003, 21 : 1213 - 1238
  • [47] Treatment pathways and associated costs of metastatic colorectal cancer in Greece
    Sougklakos, Ioannis
    Athanasiadis, Elias
    Boukovinas, Ioannis
    Karamouzis, Michalis
    Koutras, Aggelos
    Papakotoulas, Paulos
    Latsou, Dimitra
    Hatzikou, Magda
    Stamuli, Eugena
    Balasopoulos, Athanasios
    Sideris, Aggelos
    COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2022, 20 (01)
  • [48] Long-term costs of colorectal cancer treatment in Spain
    Julieta Corral
    Xavier Castells
    Eduard Molins
    Pietro Chiarello
    Josep Maria Borras
    Francesc Cots
    BMC Health Services Research, 16
  • [49] Screening, prevention and socioeconomic costs associated with the treatment of colorectal cancer
    Redaelli, A
    Cranor, CW
    Okan, GJ
    Reese, PR
    PHARMACOECONOMICS, 2003, 21 (17) : 1213 - 1238
  • [50] New guidance addresses CGMPs for investigational drugs, including biologicals
    不详
    BIOPHARM INTERNATIONAL, 2006, 19 (02) : 12 - 12
12345